Site Search

Share

X

Search Results

National Screening Survey

Overview The American Cancer Society Cancer Action Network (ACS CAN) empowers advocates across the country to make their voices heard and influence evidence-based public policy change, as well as legislative and regulatory solutions to reduce the cancer burden. As part of this effort, ACS CAN deploys surveys to better understand cancer patient and survivor experiences and perspectives, through our Survivor Views ... percent of those who do not have a regular primary care doctor report having been more than a year behind on their recommended screenings. Cost is the Single Most Frequently Mentioned Reason for Falling Behind When asked the main reason for being behind on routine cancer screenings, ...

Step Therapy in Medicare Part D Oncology Drugs

... Drug Plans (PDPs), to control prescription drug spending. While UM is used to lower plan spending and premiums for beneficiaries, it can also make it more difficult for patients to access the prescriptions they need, especially high-cost oncology drugs. To better understand how UM is used in Medicare, the American Cancer Society Cancer Action Network (ACS CAN) engaged Avalere ... and UM by plan type. Differences in tiering occurred within Special Needs Plans (SNPs), which placed the four drugs on the specialty tier 45% of the time and the preferred brand tier 55% of the time. [1] All non-SNP MA-PDs and all standalone PDPs placed the four drugs on the specialty ...

Improving Access to Biomarker Testing

The knowledge and practice of precision medicine in cancer have been progressing rapidly and advances have led to targeted cancer therapies that can improve patient survival and quality life. Treatment with targeted therapy often requires diagnostic testing to analyze biological samples ... clinical use does not always follow, and testing rates lag behind clinical guideline recommendations. As highlighted in a recent ACS CAN survey of cancer patients and survivors, only one-third of respondents reported having biomarker testing. Of those who reported not receiving biomarker ...

The Facts About Medicaid and Cancer

Medicaid provides essential health coverage to millions of lower income individuals in the U.S. It is funded jointly by the federal and state governments. Because access to health insurance coverage is a key factor in preventing, catching and treating cancer, the American Cancer Society Cancer Action Network (ACS CAN) encourages policymakers to ensure that this vital health coverage program is available to people who need it, particularly those with cancer ... their Medicaid benefits. [10] The program has encountered significant obstacles, including high administrative costs: the program has already cost nearly $26 million to implement, with 90% of funding directed toward administrative expenses, including application processing and work ...

Cancer Patients and Survivors Overwhelmingly Agree Biomarker Testing Improved Their Treatment

Overview The American Cancer Society Cancer Action Network (ACS CAN) empowers advocates across the country to make their voices heard and influence evidence-based public policy change, as well as legislative and regulatory solutions that will reduce the cancer burden. As part of this effort, ACS CAN deploys surveys to better understand cancer patient and survivor experiences and perspectives, through our Survivor Views ... using a plan purchased privately such as through the marketplace. Nine percent of those who did not have biomarker testing say it was because of cost or coverage concerns. This is a significant improvement since the last time this question was asked in 2020, when 29% mentioned cost and ...

Medicaid Work Requirements Jeopardize Cancer Patients & Survivors

... that provides comprehensive health coverage for certain individuals, including those with limited incomes and disabilities. The vast majority of those with Medicaid who can work already do so; nationally, 92% of individuals with Medicaid coverage under age 65 who do not receive Social Security disability benefits ... program, far short of the state’s goal of 100,000 participants in its first year. [viii] High Administrative Costs: The program has already cost nearly $26 million to implement, with 90% of funding directed toward administrative expenses, including application processing and work ...

Survivor Views: Patient Satisfaction by Gender

Overview The American Cancer Society Cancer Action Network (ACS CAN) gives voice to cancer patients and survivors on critical public policy issues that affect their lives.  As part of this effort, ACS CAN deploys surveys to better understand cancer patient and survivor experiences and perspectives, through our Survivor Views ... as a result of their self-advocacy and follow-up. Seventeen percent felt they needed follow up care but did not seek it due to concerns about cost or coverage. Detailed Survey Findings: Women Twice as Likely as Men to Report Middling Ratings of Their Experiences Overall, the vast majority ...

Survivor Views: One in Ten Impacted by Recent Drug Shortages

Overview The American Cancer Society Cancer Action Network (ACS CAN) empowers advocates across the country to make their voices heard and influence evidence-based public policy change, as well as legislative and regulatory solutions that will reduce the cancer burden. As part of this effort, ACS CAN deploys surveys to better understand cancer patient and survivor experiences and perspectives, through our Survivor Views ... they were a good candidate for it, however most (69%) did not discuss it with their doctor. Nine percent did not have biomarker testing due to cost or coverage concerns. Telehealth Four-in-five agree it is important for cancer patients to have access to telehealth services from out of ...

Understanding Biologic and Biosimilar Drugs

  Biologics basics Biological drugs, commonly referred to as biologics, are a class of drugs that are produced using a living system, such as a microorganism, plant cell, or animal cell. Like all drugs, biologics are regulated by ... Biologics have been a part of medical treatment for a long time and have been used for treating cancer since the 1980s. Biologics can be used to treat cancer in a variety of ways. One way, immunotherapy, helps the body’s own immune system fight cancer cells.  Other ... were introduced Biosimilars were introduced to the market in an effort to increase competition and reduce drug costs. In general, biologics cost more to develop and manufacture than small molecule drugs. They also take a longer time to bring to market (10 to 15 years versus 7 to 10 ...

Cancer Patients Need Access to Comprehensive Health Insurance

Consumers need access to health insurance policies that cover a full range of evidence-based health care services – including prevention and primary care – necessary to maintain health, avoid disease, overcome acute ... Important to Cancer Patients? Individuals with cancer and cancer survivors have unique health care needs and require access to a wide range of products and services, including oncology services, chemotherapy, radiation, prescription drugs and hospital services.  Consumers who enroll in ... Providing coverage of essential health benefits like preventive services such as cancer screenings helps to prevent some forms of cancer and can help detect other cancers at an earlier stage when the individual has a higher likelihood of more treatment options and a better overall health ...

Type

Priority Issue

State

Policy Issue

Judicial Advocacy